Dr Marta Rychert.
Rutherford Discovery Fellowships support the development of future research leaders. Ten prestigious Fellowships of five years in length are awarded on a competitive basis annually, for research based in a New Zealand host institution.
Dr Rychert has been awarded the Fellowship for her research investigating digital and social media influence strategies of the emerging international legal cannabis industry and cannabis vaping sector.
She says she is humbled to be a Fellowship recipient.
“I’m excited to be able to lead this research that will inform cannabis and vaping policy in Aotearoa. I am especially grateful to my academic mentors, colleagues, the research teams I worked with and the PhD students I supervised over the years at Massey.”
Dr Rychert’s research
The legalisation of cannabis by select states and countries, and the development of vaping technologies have collided, creating the biggest change in the addictive substances space in decades. Aotearoa New Zealand has grappled with the cannabis debate on legalisation for medical use and held a national referendum on cannabis reform in 2020. Recent cannabis policy reform and cannabis vaping has the potential to improve public health and social equity by reducing arrests and the pulmonary health effects from smoking, particularly among Māori and Pacific Peoples.
However, there is also a risk of creating new harms, including from commercial industry actors primarily focused on profit, and the targeting of Māori, Pacific Peoples and vulnerable populations such as youth. This research programme will provide the first large scale examination of these issues within the cannabis industry of Aotearoa.
In this Rutherford Discovery Fellowship, new digital and social media monitoring tools will be blended with conventional research methods to analyse the ‘influence strategies’ used by commercial actors to shape public policy and create pro-consumption environments. A large-scale online survey of frequent cannabis users in Aotearoa will be conducted, with a particular focus on Māori and Pacific Peoples. This survey will explore the influence of industry messages, and measure cannabis vaping uptake under the new medicinal cannabis regime.
Dr Rychert and her collaborators, including experts in industry influence, drug policy and Māori health, will also investigate the role that major United States and Canadian industry actors play in promoting market-friendly narratives in new countries and regions.
This Rutherford Discovery Fellowship will make a significant theoretical contribution to the commercial determinants of health, providing much needed evidence for policy and regulatory responses to cannabis in Aotearoa.
About Dr Rychert
Dr Rychert received her PhD in 2017 in public health from Te Kunenga ki Pūrehuroa Massey University. She has since worked her way up to Senior Research Officer in the SHORE & Whāriki Research Centre in Auckland. She is a co-Editor-in-Chief of international drug policy journal Drugs, Habits and Social Policy. In 2018 and 2019 her work was nominated for the Best Early Career Researcher award by the International Society for the Study of Drug Policy. Her research has been supported by multiple competitive grants, including from the Health Research Council of New Zealand and the Marsden Fund.
Dr Rychert’s expertise intersects health, policy and law, with a particular focus on the socio-legal and policy challenges of drug law reform, harm minimisation, social equity and public health. She has also developed an interdisciplinary research portfolio in health law and professional misconduct, wherein she analyses structural drivers of professional misconduct and improved models of rehabilitation.
Read more about the Fellowships here.
Related news
Survey shows increased vaping of nicotine e-liquids
Findings from the 2022/23 New Zealand Drugs Trends Survey (NZDTS) show an increase in nicotine e-liquid vaping, but a decline in the use of no-nicotine e-liquids.
Survey shows Northland and the South Island have higher levels of meth purchasing from gangs
The second release of findings from the 2022/23 New Zealand Drugs Trends Survey shows increased levels of meth purchasing from gangs, and the emergence of social media and darknet drug markets.
Drug Trends Survey shows increase in cannabis availability, while meth prices continue to drop
Findings from the 2022/23 New Zealand Drug Trends Survey show a sharp increase in cannabis availability and decrease in price, as well as an ongoing decline in the price of methamphetamine.